Premium
Prescribing outside of a drug's licence: issues and implications
Author(s) -
Chisholm Alison
Publication year - 2013
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1036
Subject(s) - medicine , bevacizumab , drug , focus (optics) , family medicine , pharmacology , surgery , physics , chemotherapy , optics
The GMC recently published updated guidance on prescribing outside of a medication's licence. Here, we examine the drivers and implications for off‐label prescribing, with a particular focus on the issues surrounding the prescribing of bevacizumab in wet AMD.